Who Is Wynk? A Brand File on the Engineer-Built THC Seltzer

Wynk is the inverse of the usual drinks-brand transparency profile. Most THC beverage companies are marketing shops sitting on top of an unnamed co-packer; the mystery is who actually makes the drink. Wynk makes its own drink, owns its plant, patented its dosing hardware, and names its extract supplier. The mystery is elsewhere: who runs its lab tests, and whose money is behind it.

That's why a brand with a genuinely great manufacturing story lands at a C rather than a B. Our score rewards what you can verify end to end, and Wynk's chain has two unverifiable links: the COAs are full-panel and easy to pull up, but the lab that produced them is never named, and the parent company's funding is a black box. Add a thin independent review trail and you get a 78: high for a C, with an obvious path upward.

Wynk clears a bar many brands in these files fail: every founder is named, public, and verifiable. Casey Parzych is co-founder and CEO, a Carnegie Mellon graduate who interned at SpaceX in 2012. Angus Rittenburg is a co-founder and engineer whose resume runs through Tesla's Model 3 battery program, SpaceX, and Google. Shawn Sheehan is the third co-founder, a career energy trader from XO Energy. In 2022 the company added named beverage-industry veterans (including an ex-MillerCoors executive, Aguirre) to the team; to be precise, those are hires, not founders, though some coverage blurs that line.

This is Wynk's strongest pillar, and it's worth telling properly. Most THC drinks are made by contract co-packers the brand won't name; Wynk's stated position is the opposite: 'we craft our own product,' with no co-packers at all. And the way it got there is genuinely clever.

• The Wynk Wagon. Because THC can't legally cross certain state lines, the founders built a 53-foot mobile canning line capable of about 30,000 cans a day, so production could happen where the rules required it. An engineering answer to a regulatory problem.
• The Waverly plant. The wagon grew into a roughly 500,000-square-foot facility in Waverly, New York, owned and operated by the company, with patented bottom-valve dosing technology designed to put a precise cannabinoid dose in every can.
• A named extract supplier. The cannabinoids come from Open Book Extracts, an NSF cGMP-registered, ISO 9001-certified extractor. Naming your supplier, with credentials you can check, is a bar most beverage brands never attempt.

Compare that to Cann, the category's celebrity darling, which won't name its co-packer at all. On the who-makes-it question, Wynk is about as transparent as this category gets.

Wynk's testing program gets a lot right. Every can carries a QR code that resolves to a batch-specific, full-panel Certificate of Analysis, and the company runs a public COA lookup on its site. Full panels tied to batches, one scan away, is exactly the access we want, and it's better than most of the category delivers.

The record is clean, and we checked rather than assumed. We found no FDA warning letter, no FTC action, no lawsuits, and no recalls involving Wynk or Wherehouse Beverage Co. The closest thing to a regulatory entry in our search was testimony before a Connecticut legislative committee in 2024, which is participation in a policy debate, not enforcement, and we count it as exactly that. The honest caveat cuts the other way: Wynk's independent review footprint is thin. There's little third-party coverage, few aggregated consumer reviews, and not much outside corroboration, so more of the story rests on the company's own telling than we'd like.

In our view, Wynk is what happens when engineers, rather than marketers, build a THC drink: the physical side of the business is unusually transparent, and the paper side hasn't caught up. If your question is 'who actually makes this, where, and from what,' Wynk answers it better than almost any beverage brand we've filed: its own plant, its own patented dosing line, a named and credentialed extract supplier, and a full-panel COA on every can. If your question is 'who tested it and whose money is behind it,' the answers are 'an unnamed lab' and 'undisclosed,' and that's the difference between a C and a B.

We've graded it a C (78/100), at the top of the band, and it's one of the most fixable profiles in this series: name the testing lab, disclose even the outline of the funding, and this file gets rewritten upward. The full methodology shows every point, and if Wynk publishes its lab's name, we'll update the file (see the notice below).